Gain Therapeutics, Inc.

GANX·NasdaqGM
Compare
1.5700−0.0700 (−4.27%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.6400
Open1.6500
Day range1.56501.6500
52-week range1.53004.3400
Off day high−4.85%
Off 52-week high−63.82%
Volume319.40K
Avg. volume (3M)489.58K
Market cap68.52M
EPS (TTM)-0.5000
Forward P/E-2.28
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding43.64M
Short interest—
Earnings dateAug 6, 2025 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
GANX ALEC VYGR ADXN ATHE PMN
Market cap 68.52M 232.25M 139.87M 5.33M 53.35M 84.74M
P/E (TTM) — — — — — —
Forward P/E -2.3 -2.8 -1.8 -60.8 -3.1 -2.1
Price/book 6.0 -23.4 0.9 1.4 1.8 1.7
Dividend yield — — — — — —
1-year change −13.68% −30.43% −49.90% −64.32% −38.05% −19.92%
Today −4.27% 0.00% −7.35% −5.55% −6.98% −1.66%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All GANX news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.